{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:31:38Z","timestamp":1756384298783,"version":"3.40.5"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Haiphong University of Medicine and Pharmacy"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Drug-induced liver injury (DILI) is a rare side effect of angiotensin-converting enzyme inhibitors (ACEIs). Ramipril is a widely used ACE compound because of its effectiveness in the treatment of hypertension and heart failure, as well as its low risk of adverse effects. However, the clinical features of ramipril, and the risk of DILI, have not been adequately studied. A retrospective cohort study was performed based on data from 3909 inpatients to compare the risk of DILI conferred by ramipril and other ACEIs. A logistic regression model was then constructed and validated against data from 1686 patients using ramipril, of which 117 patients were diagnosed with DILI. The use of ramipril increased the risk of DILI by 2.68 times (odds ratio = 2.68; 95% confident interval (CI):1.96\u20133.71) compared with the group using other ACEIs. The clinical features of DILI in the ramipril group were similar to those from the ACEI group (P&gt;0.05), except that the ALT level was higher (P&lt;0.05). A logistic regression model including Body mass index (BMI), comorbidity, liver disease, daily dose, alanine aminotransferase (ALT), and alkaline phosphatase (ALP) was built and successfully validated for DILI risk prediction, with the area under the receiver operating characteristic curve of the model of 0.82 (95% CI: 0.752\u20130.888). We recommend that clinicians should be aware of the levels of ALT and ALP as well as BMI, comorbidities, and liver disease before prescribing ramipril to avoid the risk of DILI in patients.<\/jats:p>","DOI":"10.1371\/journal.pone.0272786","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T17:32:15Z","timestamp":1660757535000},"page":"e0272786","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["A logistic regression model based on inpatient health records to predict drug-induced liver injury caused by ramipril\u2014An angiotensin-converting enzyme inhibitor"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-0852","authenticated-orcid":true,"given":"Phuong Nguyen","family":"Thi Thu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai Ngo Thi","family":"Quynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung Nguyen","family":"Van","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoi Nguyen","family":"Thanh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2974-3484","authenticated-orcid":true,"given":"Khue Pham","family":"Minh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"issue":"5","key":"pone.0272786.ref001","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMra021844","article-title":"Drug-induced hepatotoxicity","volume":"349","author":"WM Lee","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0272786.ref002","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-2002-30105","article-title":"Epidemiology and individual susceptibility to adverse drug reactions affecting the liver","volume":"22","author":"D Larrey","year":"2002","journal-title":"Semin Liver Dis"},{"issue":"3","key":"pone.0272786.ref003","doi-asserted-by":"crossref","first-page":"477v","DOI":"10.1016\/j.cld.2007.06.003","article-title":"Causality assessment of drug-induced hepatotoxicity: promises and pitfalls","volume":"11","author":"MA Shapiro","year":"2007","journal-title":"Clin Liver Dis"},{"issue":"6","key":"pone.0272786.ref004","doi-asserted-by":"crossref","first-page":"192434.e1","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"N Chalasani","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"pone.0272786.ref005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cld.2012.03.002","article-title":"Drug-induced liver disease","volume":"16","author":"TJ Davern","year":"2012","journal-title":"Clin Liver Dis"},{"key":"pone.0272786.ref006","first-page":"w13080","article-title":"Liver injury caused by drugs: an update","volume":"140","author":"G Stirnimann","year":"2010","journal-title":"Swiss Med Wkly"},{"issue":"Suppl 2","key":"pone.0272786.ref007","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1097\/00005344-199106182-00031","article-title":"Tolerability of ramipril in a multicenter study of mild-to-moderate hypertension in general practice","volume":"18","author":"A Carre","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"pone.0272786.ref008","first-page":"110","article-title":"Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders","volume":"39","author":"PA Todd","year":"1990","journal-title":"Drugs"},{"issue":"2","key":"pone.0272786.ref009","first-page":"143","article-title":"Ramipril-associated cholestasis in the setting of recurrent drug-induced liver injury","volume":"10","author":"D Forner","year":"2017","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"9","key":"pone.0272786.ref010","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/ajh\/hpt090","article-title":"Ramipril-induced liver injury: case report and review of the literature","volume":"26","author":"A Douros","year":"2013","journal-title":"Am J Hypertens"},{"issue":"2","key":"pone.0272786.ref011","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40264-017-0598-y","article-title":"Overview of Pharmacovigilance System in Vietnam: Lessons Learned in a Resource-Restricted Country","volume":"41","author":"KD Nguyen","year":"2018","journal-title":"Drug Saf"},{"issue":"1","key":"pone.0272786.ref012","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jcpt.13037","article-title":"Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam","volume":"45","author":"TT Le","year":"2020","journal-title":"J Clin Pharm Ther"},{"issue":"11","key":"pone.0272786.ref013","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2014I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"G Danan","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"pone.0272786.ref014","unstructured":"R: TR. A language and environment for statistical computing. R Foundation for Statistical Computing. 2005."},{"issue":"1","key":"pone.0272786.ref015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"JA Hanley","year":"1982","journal-title":"Radiology"},{"issue":"1","key":"pone.0272786.ref016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1175\/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2","article-title":"Verification of forecasts expressed in terms of probability","volume":"78","author":"GWJ Brier","year":"1950","journal-title":"Mwr"},{"issue":"11","key":"pone.0272786.ref017","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0895-4356(91)90146-Z","article-title":"Assessing predictive accuracy: how to compare Brier scores","volume":"44","author":"DA Redelmeier","year":"1991","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"pone.0272786.ref018","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00000441-200110000-00016","article-title":"Captopril-induced jaundice: report of 2 cases and a review of 13 additional reports in the literature","volume":"322","author":"A Schattner","year":"2001","journal-title":"Am J Med Sci"},{"issue":"4","key":"pone.0272786.ref019","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/014107689008300422","article-title":"Enalapril-related cholestatic jaundice","volume":"83","author":"P Todd","year":"1990","journal-title":"J R Soc Med"},{"key":"pone.0272786.ref020","unstructured":"Enalapril. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD)2012."},{"issue":"11","key":"pone.0272786.ref021","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.5858\/2003-127-1493-RH","article-title":"Ramipril-associated hepatotoxicity","volume":"127","author":"E Yeung","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"16","key":"pone.0272786.ref022","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.2146\/ajhp100083","article-title":"Unique case of presumed lisinopril-induced hepatotoxicity","volume":"67","author":"SK Zalawadiya","year":"2010","journal-title":"Am J Health Syst Pharm"},{"issue":"34","key":"pone.0272786.ref023","doi-asserted-by":"crossref","first-page":"e4683","DOI":"10.1097\/MD.0000000000004683","article-title":"The characteristics and clinical outcome of drug-induced liver injury in a Chinese hospital: A retrospective cohort study","volume":"95","author":"SS Chen","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"pone.0272786.ref024","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.28678","article-title":"A Model to predict severity of drug-induced liver injury in humans","volume":"64","author":"M Chen","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"pone.0272786.ref025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003088-199426010-00002","article-title":"Clinical pharmacokinetics of ramipril","volume":"26","author":"S Meisel","year":"1994","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"pone.0272786.ref026","first-page":"1243","article-title":"Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?","volume":"12","author":"RA Wu","year":"1994","journal-title":"J Hypertens"},{"issue":"5","key":"pone.0272786.ref027","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1053\/j.gastro.2019.07.006","article-title":"Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury","volume":"157","author":"M Ghabril","year":"2019","journal-title":"Gastroenterology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0272786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T17:32:43Z","timestamp":1660757563000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0272786"}},"subtitle":[],"editor":[{"given":"Jorge Enrique","family":"Machado-Alba","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0272786","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2022,8,17]]}}}